Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.
HER2/Neu Status
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
UNLABELLED
Gemcitabine is a potent chemotherapeutic that exerts cytotoxic activity against several leukemias and a wide spectrum… Expand
2011
2011
Background:We evaluated shedding of epidermal growth factor type II receptor (Her2/neu) extracellular domain (ECD) in primary… Expand
2010
2010
1527 Background: COX-2 is overexpressed in many epithelial malignancies, including a subset of human breast cancers. Preclinical… Expand
2009
2009
Gene silencing, demethylation, translocations and amplifications crucially contribute to the growth potential and aggressiveness… Expand
2008
2008
Pagetoid dyskeratosis (PD) is considered a selective keratinocytic response in which a small part of the normal population of… Expand
2007
2007
BACKGROUND AND OBJECTIVE
To investigate the prognostic value of p53 and HER2/neu overexpression in epithelial ovarian cancer (EOC… Expand
Highly Cited
2002
Highly Cited
2002
Overexpression of the oncogene HER2/neu (c-erbB-2) occurs in up to 30% of breast cancers and is correlated with reduced survival… Expand
Highly Cited
1993
Highly Cited
1993
The HER2/neu oncogene encodes a transmembrane protein that possesses intrinsic tyrosine kinase activity. Its overexpression has… Expand
Highly Cited
1988
Highly Cited
1988
The HER2/neu protooncogene was found to be amplified in 6 of 109 primary adenocarcinoma tumors. No HER2/neu amplification was… Expand